Webvent

SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Exalt Clinical Research

Exalt. Elevating Clinical Research. Elevating the clinical research trial experience through robust, diverse enrollment, quality data, and responsive communication.

Exalt Clinical Research

Exalt Clinical Research is grounded in providing a best-in-class trial experience for patients, sponsors, and CROs through progressive recruitment practices and compassionate patient care resulting in the smooth initiation and execution of early through late phase clinical trials.

Founder, Dixie L. Creager is an experienced multi-location manager of clinical and business operations for over 30 years. Based on this experience, she identified the South Bay as an opportunity to be a part of a dynamic, diverse community.  

Information

Demographic Data

  • SITE INFORMATION 
  • Start year clinical research2023
  • Phases of clinical studiesPhase I, Phase II, Phase III
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • SPECIFIC SITE INFORMATION 
  • Type of siteFreestanding
  • # of employees involved in research14
  • # of investigators5
  • Number of studies last year3
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday
  • Extended office hoursYes
  • Overnight facilitiesYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS
  • REGULATORY INFORMATION 
  • Contact for regulatory documentsNicolette Estrada
  • Regulatory phone number16198268884
  • # of days to turn around regulatory documents5
  • Type of IRB used by this siteCentral
  • How often does your local IRB meet?Weekly
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • FINANCIAL INFORMATION 
  • # days to turn around budget and contract5